Recombinant Human Agrin Protein, N-terminal, CF Summary
Details of Functionality
Measured by its ability to inhibit neurite outgrowth of E16-E18 rat embryonic cortical neurons on a Laminin alpha 4 coated plate. Able to significantly inhibit neurite outgrowth when immobilized as a 3 μL droplet containing 50 ng of protein.
Source
Chinese Hamster Ovary cell line, CHO-derived human Agrin protein Thr30-Arg1102, with a C-terminal 6-His tag
<0.10 EU per 1 μg of the protein by the LAL method.
Applications/Dilutions
Dilutions
Bioactivity
Theoretical MW
113 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
SDS-PAGE
138-181 kDa, reducing conditions
Publications
Read Publication using 8909-AG in the following applications:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
3 months, -20 to -70 °C under sterile conditions after reconstitution.
Buffer
Lyophilized from a 0.2 μm filtered solution in PBS.
Purity
>95%, by SDS-PAGE with silver staining.
Reconstitution Instructions
Reconstitute at 500 μg/mL in PBS.
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Recombinant Human Agrin Protein, N-terminal, CF
agrin proteoglycan
Agrin
AGRN
Background
Agrin is a 400-600 kDa heparan sulfate proteoglycan component of the extracellular matrix. The N-terminal half of human Agrin, which mediates ECM interactions, contains a Laminin-binding NtA domain, nine Follistatin-like/Kazal-type protease inhibitor domains, two Laminin EGF-like domains, and one SEA domain. The C-terminal half contains four EGF-like repeats and three Laminin globular G domains. Rat Agrin lacks the NtA domain, and mouse and chick Agrin include the NtA domain only by the use of an alternate promoter. Additional isoforms are generated by alternative splicing at sites Y and Z in the C-terminal half of rat Agrin (known as A and B, respectively in chick). Agrin isoforms that contain an insert at site Z (Z+ forms) are known as neural Agrin and are selectively produced by motoneurons. Other isoforms are known as muscle Agrin and are additionally expressed in non-neuronal tissues, particularly in basement membranes of the lung and kidney (1-3). In addition, multiple proteolytic fragments of Agrin are produced by Neurotrypsin, MMP-1, -7, -12, and -14 (4, 5). This recombinant protein consists of the N-terminal region of human Agrin (up to the Neurotrypsin alpha -cleavage site upstream of the SEA domain) (4). It shares 80% amino acid sequence identity with comparable regions of mouse and rat Agrin. The N-terminal region binds to BMP-2, BMP-4, and TGF-beta, and it blocks BMP-induced signaling through BMPR1A (6). The C-terminal half of Z- and Z+ Agrin binds to alpha -Dystroglycan and mediates adhesion between motoneurons and myotubes at the neuromuscular junction (NMJ) (7-9). In contrast, only Z+ Agrin is effective at inducing clustering of the postsynaptic Acetylcholine Receptor (AChR) and presynaptic motoneuron differentiation (10, 11). Agrin-induced AChR clustering requires a myotube receptor complex that contains alpha -Dystroglycan, MuSK, and LRP4 (7, 12-14). Agrin exhibits many functions in addition to NMJ development. It is enriched in senile Alzheimer’s disease plaques where it binds the A beta (1-40) peptide and promotes amyloid fibril formation (15). It regulates neuronal excitability by binding and inhibiting the alpha 3 subunit of the neuronal Na/K ATPase (16). It functions as an epithelial cell attachment receptor for HIV-1 through interactions with the gp41 coat protein (17). During T cell activation, Agrin contributes to formation of the immunological synapse and regulates the threshold of T cell activation (18). Agrin is up-regulated in hepocellular carcinoma, where it enhances cell proliferation and tumor progression (19).
Jury, E.C. and P.S. Kabouridis (2010) Arthritis Res. Ther. 12:205.
Bezakova, G. and M.A. Ruegg (2003) Nat. Rev. Mol. Cell Biol. 4:295.
Groffen, A.J.A. et al. (1998) Eur. J. Biochem. 254:123.
Reif, R. et al. (2007) FASEB J. 21:3466.
Patel, T.R. et al. (2012) PLoS ONE 9:e43669.
Banyai, L. et al. (2010) PLoS ONE 5:e10758.
Gee, S.H. et al. (1994) Cell 77:675.
Sugiyama, J. et al. (1994) Neuron 13:103.
Gesemann, M. et al. (1998) J. Biol. Chem. 273:600.
Burgess, R.W. et al. (1999) Neuron 23:33.
Ferns, M.J. et al. (1993) Neuron 11:491.
Glass, D.J. et al. (1996) Cell 85:513.
Kim, N. et al. (2008) Cell 135:334.
Zhang, B. et al. (2008) Neuron 60:285.
Cotman, S.L. et al. (2000) Mol. Cell. Neurosci. 15:183.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our Recombinant Human Agrin Protein, N-terminal, CF and receive a gift card or discount.